303 related articles for article (PubMed ID: 30683268)
1. Endometrial Cancer: Obesity, Genetics, and Targeted Agents.
McDonald ME; Bender DP
Obstet Gynecol Clin North Am; 2019 Mar; 46(1):89-105. PubMed ID: 30683268
[TBL] [Abstract][Full Text] [Related]
2. Endometrial carcinoma tumorigenesis and pharmacotherapy research.
Shu J; Fang S; Teichman PG; Xing L; Huang H
Minerva Endocrinol; 2012 Jun; 37(2):117-32. PubMed ID: 22691886
[TBL] [Abstract][Full Text] [Related]
3. Hormonal therapy of endometrial cancer.
Markman M
Eur J Cancer; 2005 Mar; 41(5):673-5. PubMed ID: 15763641
[TBL] [Abstract][Full Text] [Related]
4. An update on the current pharmacotherapy for endometrial cancer.
de Haydu C; Black JD; Schwab CL; English DP; Santin AD
Expert Opin Pharmacother; 2016; 17(4):489-99. PubMed ID: 26629895
[TBL] [Abstract][Full Text] [Related]
5. Endometrial cancer-targeted therapies myth or reality? Review of current targeted treatments.
Lheureux S; Oza AM
Eur J Cancer; 2016 May; 59():99-108. PubMed ID: 27017291
[TBL] [Abstract][Full Text] [Related]
6. Endometrial cancer: Molecular markers and management of advanced stage disease.
Arend RC; Jones BA; Martinez A; Goodfellow P
Gynecol Oncol; 2018 Sep; 150(3):569-580. PubMed ID: 29843906
[TBL] [Abstract][Full Text] [Related]
7. Micronized estradiol and progesterone therapy in primary, preinvasive endometrial cancer (1A/G1) in young women with polycystic ovarian syndrome.
Stanosz S; von Mach-Szczypiński J; Sieja K; Koœciuszkiewicz J
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2472-6. PubMed ID: 25157541
[TBL] [Abstract][Full Text] [Related]
8. [Systemic therapy for advanced endometrial cancer].
Pautier P; Pommeret F
Bull Cancer; 2017 Dec; 104(12):1046-1053. PubMed ID: 29157555
[TBL] [Abstract][Full Text] [Related]
9. Emerging drugs for endometrial cancer.
Amadio G; Masciullo V; Ferrandina MG; Scambia G
Expert Opin Emerg Drugs; 2014 Dec; 19(4):497-509. PubMed ID: 25330855
[TBL] [Abstract][Full Text] [Related]
10. Endometrial cancer: reviving progesterone therapy in the molecular age.
Yang S; Thiel KW; De Geest K; Leslie KK
Discov Med; 2011 Sep; 12(64):205-12. PubMed ID: 21955848
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in systemic therapy for advanced endometrial cancer.
Tsoref D; Oza AM
Curr Opin Oncol; 2011 Sep; 23(5):494-500. PubMed ID: 21673575
[TBL] [Abstract][Full Text] [Related]
12. Molecular targets and targeted therapeutics in endometrial cancer.
Weigelt B; Banerjee S
Curr Opin Oncol; 2012 Sep; 24(5):554-63. PubMed ID: 22581357
[TBL] [Abstract][Full Text] [Related]
13. [The mechanisms of progesterone treatment on endometrial carcinoma].
Chen C; Hua Z; Jin X
Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):415-7. PubMed ID: 9639728
[TBL] [Abstract][Full Text] [Related]
14. [Hormonal therapy for endometrial adenocarcinoma].
Susumu N; Aoki D; Suzuki N; Nozawa S
Gan To Kagaku Ryoho; 2001 Jul; 28(7):934-45. PubMed ID: 11478142
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of endometrial cancer.
Barrena Medel NI; Bansal S; Miller DS; Wright JD; Herzog TJ
Expert Opin Pharmacother; 2009 Aug; 10(12):1939-51. PubMed ID: 19586421
[TBL] [Abstract][Full Text] [Related]
16. Randomized evidence on chemotherapy and hormonal therapy regimens for advanced endometrial cancer: an overview of survival data.
Polyzos NP; Pavlidis N; Paraskevaidis E; Ioannidis JP
Eur J Cancer; 2006 Feb; 42(3):319-26. PubMed ID: 16376072
[TBL] [Abstract][Full Text] [Related]
17. Hormonal treatment of endometrial cancer: past, present and future.
Podczaski E; Mortel R
Best Pract Res Clin Obstet Gynaecol; 2001 Jun; 15(3):469-89. PubMed ID: 11476566
[TBL] [Abstract][Full Text] [Related]
18. Developments in the systemic treatment of endometrial cancer.
Mountzios G; Pectasides D; Bournakis E; Pectasides E; Bozas G; Dimopoulos MA; Papadimitriou CA
Crit Rev Oncol Hematol; 2011 Sep; 79(3):278-92. PubMed ID: 20833559
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy in metastatic or recurrent endometrial carcinoma].
Deppe G; Baumann P; Munkarah A
Zentralbl Gynakol; 2000; 122(7):355-60. PubMed ID: 10951705
[TBL] [Abstract][Full Text] [Related]
20. Anastrozole, an aromatase inhibitor, and medroxyprogesterone acetate therapy in premenopausal obese women with endometrial cancer: a report of two cases successfully treated without hysterectomy.
Burnett AF; Bahador A; Amezcua C
Gynecol Oncol; 2004 Sep; 94(3):832-4. PubMed ID: 15350383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
